Outpatient Neutropenic Diet Study
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of this study is to evaluate the infection rate of leukemia patients who eat two different diets. Patients in the "raw" group will eat cooked food and the addition of raw fruits and vegetables. Patients in the "cooked" group will eat only cooked foods and this is the standard neutropenic diet with no fresh fruits or vegetables allowed. The primary objective of the study is to evaluate the infection rate of leukemia patients who eat two different diets. The secondary objectives will be the incidence of fever requiring intravenous antibiotics in each group and death rate.
| Condition | Intervention | Phase |
|---|---|---|
|
Leukemia Neutropenia |
Other: Raw Fruits & Vegetables Other: Cooked Foods |
Phase 2 |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Open Label |
| Official Title: | Are Neutropenic Diets Beneficial to Improve Outcome? |
- Infection Rate [ Time Frame: 6 weeks ] [ Designated as safety issue: No ]
| Enrollment: | 30 |
| Study Start Date: | July 2009 |
| Primary Completion Date: | March 2013 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
"Raw" Group
Participants will eat cooked food and the addition of raw fruits and vegetables.
|
Other: Raw Fruits & Vegetables
Diet containing fresh fruits and vegetables in addition to cooked food.
|
|
"Cooked" Group
Participants will eat only cooked foods.
|
Other: Cooked Foods
Diet containing only cooked foods.
|
Detailed Description:
This study is comparing two different diets. The cooked group will be allowed to eat only cooked food and cooked fruits or vegetables. The raw group will be able to eat cooked food and the addition of fresh fruits and vegetables. Patients will be monitored for infection in both groups. There are still certain foods that you are restricted from eating while receiving chemotherapy and you will be given a list of these restrictions.
Study Groups:
If you agree to take part in this study, you will be randomly assigned (as in the flip of a coin) to 1 of 2 groups.
Group 1: Raw group: You will be asked to eat at least 1 raw fruit or vegetable every day you are on study.
Group 2: Cooked group: You will eat only cooked foods while on study. The study doctor will give you a list of the foods that you are allowed to eat.
Your medical chart will be monitored while you are on study to check how often you need antibiotics to treat fever. or if you have an infection.
Diet Questionnaire:
You will be asked to fill out a diet questionnaire every week. The questionnaire will have 5 questions about the foods you have been eating. If you have been released from the hospital, you can return the questionnaire during your scheduled hospital visits,which typically take place 3 times per week. You will have no additional visits during this study. The questionnaire should take about 1-2 minutes each time.
Length of Study:
You will be taken off study if your white blood cell count returns to normal. If your white blood cell counts do not return to normal, the maximum time that you may be on study is 6 weeks.
This is an investigational study. There has not been enough research to prove if raw fruits and vegetables can increase your risk of infection. Many hospitals allow neutropenic patients to eat raw fruits and vegetables and other hospitals restrict fresh fruits and vegetables but, this has not been adequately investigated.
Up to 128 patients will take part in this study. All will be enrolled at M. D. Anderson.
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Newly diagnosed patients with acute myelogenous leukemia (AML), acute lymphocytic leukemia ( ALL), or myelodysplastic syndrome (MDS) receiving induction chemotherapy or AML, ALL or MDS patients who are in remission receiving consolidation chemotherapy.
- Patients who will be receiving myelosuppressive chemotherapy for their disease.
- Patients who will be able to stay in the Houston area for at least 4 weeks.
- Patients who can speak either English or Spanish.
Exclusion Criteria:
- Patients who present with an active infection such as pneumonia, bacteremia, urine, c. difficile or cellulitis infection.
- Patients who are unable to understand the diet questionnaire which will be written in either English or Spanish.
- Patients who are admitted to the protective environment.
- Patients who are younger than age 18 will not be entered in the study.
- Pregnant patients.
Contacts and Locations| United States, Texas | |
| U.T. M.D. Anderson Cancer Center | |
| Houston, Texas, United States, 77030 | |
| Principal Investigator: | Alison E Gardner, PhD | M.D. Anderson Cancer Center |
More Information
Additional Information:
No publications provided
| Responsible Party: | M.D. Anderson Cancer Center |
| ClinicalTrials.gov Identifier: | NCT00947648 History of Changes |
| Other Study ID Numbers: | 2008-0369 |
| Study First Received: | July 24, 2009 |
| Last Updated: | March 28, 2013 |
| Health Authority: | United States: Institutional Review Board |
Keywords provided by M.D. Anderson Cancer Center:
|
acute myelogenous leukemia AML myelodysplastic syndrome |
MDS Neutropenia raw fruits and vegetables |
Additional relevant MeSH terms:
|
Leukemia Neutropenia Neoplasms by Histologic Type Neoplasms |
Agranulocytosis Leukopenia Leukocyte Disorders Hematologic Diseases |
ClinicalTrials.gov processed this record on May 16, 2013